期刊文献+

同种异体NK细胞对CD34^+早期急性髓系白血病细胞的细胞毒效应 被引量:4

Cytotoxicity of allogenetic natural killer cells against CD34^+ acute myelogenous leukemia cells
下载PDF
导出
摘要 目的探讨同种异体NK细胞对CD34+早期急性髓系白血病细胞的细胞毒效应。方法免疫磁珠法分离5例健康个体NK细胞,乳酸脱氢酶释放法测定不同效靶比时NK细胞对CD34+早期急性髓系白血病细胞KG1a的杀伤活性,甲基纤维素克隆形成实验检测NK细胞对KG1a细胞的克隆形成抑制率,同时与NK杀伤敏感细胞株K562比较。结果急性髓系白血病细胞株KG1a中CD34抗原表达率为(98.0±1.1)%,分选后的NK细胞(CD3-CD16+CD56+细胞)纯度为(93.2±3.7)%。不同效靶比时NK细胞对KG1a细胞均有杀伤活性,均能抑制其克隆形成。随着效靶比的增高,其杀伤活性和克隆抑制率随之增高(P<0.05)。同一效靶比时,NK细胞对KG1a的杀伤活性和克隆抑制率低于K562(P<0.05)。结论同种异体NK细胞对CD34+早期急性髓系白血病细胞具有细胞毒效应。 Objective To study the cytotoxic effect ofallogenetic natural killer (NK) cells in vitro on human CD34^+ acute myelogenous leukemia cells. Methods CD34 expression on acute myelogenous leukemia KGla cells was detected by flow cytometry. KGla cells were co-cultured at different effector-to-target (E:T) ratios with NK cells isolated from 5 healthy individuals using magnetic cell sorting. Lactate dehydrogenase (LDH) release assay was employed to examine the cytolysis of KGla cells in the co-culture, and the inhibition rate of the KGla cell colony formation in methylcellulose was determined with K562 cells sensitive to NK cells as the control. Results A expression rate as much as (98.0±1.1)% was detected for CD34 antigen on KGla cells, and the isolated NK cells (CD3-CD16^+CD56^+ cells) had a purity of (93.2±3.7)% after magnetic cell sorting. Allogenetic NK cells exhibited obvious cytotoxicity and colony inhibition in vitro against KGla cells at different E:T ratios, and the effects were significantly enhanced as the E:T ratios increased (P〈0.05). At the same E:T ratio, the cytotoxicity and colony inhibition rate of allogenetic NK cells against KGla cells was lower than those against K562 cells (P〈0.05). Conclusion Allogenetic NK cells exhibit obvious cytotoxicity and colony formation against CD34^+ acute myelogenous leukemia cells.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2008年第2期173-175,共3页 Journal of Southern Medical University
基金 国家自然科学基金(30471636)~~
关键词 NK细胞 CD34 白血病 粒性 急性 细胞毒 克隆抑制 natural killer cells CD34 leukemia, myelocytic, acute cytotoxicity clone inhibition
  • 相关文献

参考文献8

  • 1Guimaraes F, Guven H, Donati D, et al. Evaluation of ex vivo expanded human NK cells on antileukemia activity in SCID-beige mice [J ]. Leukemia, 2006, 20(5): 833-9.
  • 2Furley AJ, Reeves BR, Mizutani S, et al. Divergent molecular phenotypes of KG1 and KGla myeloid cell lines [J]. Blood, 1986, 68(5): 1101-7.
  • 3Farag SS, Van Deusen JB, Fehniger TA, et al. Biology and clinic impact of human natural killer cells [J ]. Int J Hematol, 2003, 78(1): 7-17.
  • 4Bauer S, Groh V, Wu J, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress inducible MICA [J ]. Science, 1999, 285(5428): 727-9.
  • 5Miller JS, Soignier Y, Panoskaltsis-Mortari A, et al. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer [J]. Blood, 2005, 105(8): 3051-7.
  • 6梅家转,郭坤元,魏红梅,宋朝阳.NKG2D配体在耐药鼻咽癌细胞的表达及其对NK细胞杀伤活性的影响[J].南方医科大学学报,2007,27(6):887-889. 被引量:4
  • 7柏树令,赵丹.CD34抗原的生物学特性及其临床应用[J].解剖科学进展,2005,11(1):54-56. 被引量:40
  • 8Sconocchia G, Lau M, Provenzano M, et al. The antileukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous leukemia involves NKG2D-target-cell interactions [J].Blood, 2005, 106(10): 3666-72.

二级参考文献15

  • 1邹萍,向建平,陈智超,李崇渔.急性髓系白血病细胞CD_(34)抗原表达的研究Ⅰ表达特点和临床意义[J].中华血液学杂志,1994,15(7):339-341. 被引量:28
  • 2操州虹,刘秀芳,王辨明.不同病期慢性粒细胞白血病CD_(34)阳性细胞的临床意义[J].中华血液学杂志,1996,17(1):10-12. 被引量:3
  • 3Osawa M,Hanada K, Hamada H, et al. Long-term lymphohematopoietic reconstitution by a single CD34 - low/negative hematopietic stem cell [J]. Science, 1996,273 (5272): 242 - 245.
  • 4Huss R. CD34 - stem cells as the earliest precursors of hempatopoietic progeny[J]. Exp Hematol,1998,26(11) :1022 - 1023.
  • 5Halens S, Kohn DB. Gene therapy using hematopoietic stem cells:sisyphus approaches the cerst[J]. Human Gene Therapy,2000,11(9) :1259 - 1267.
  • 6Cornelissen JJ, Vander Hdt B, Petersen EJ, et al. A randomized multicenter comparison of CD34 +-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies [J]. Exp Hematol,2003,31 (10) :855 -864.
  • 7Vogle W, Behringer D, Scheding S, et al. Ex vivo expansion of CD34 + peripheral blood progenitor cells: implications for the expansion of contaminating epithelial tumor cells[J]. Blood,1996,88(7) :2707 -2713.
  • 8Brugger W, Heimfeld S, Berenson RJ, et al. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo[J]. N Eng J Med, 1995,333 (5) :283 -287.
  • 9Harraz M, Jiao C, Hanlon HD, et al. CD34- blood-derived human endothelial cell progenitors[J]. Stem Gells,2001,19(4) :304-312.
  • 10Tahara-Hanaoka S, Sudo K, Ema H, et al. Lentiviral vector-mediated transduction of murirte CD34 - hematopoietic stem cells [J].Exp Hematol, 2002,30(1) :11 - 17.

共引文献41

同被引文献28

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部